Immunogenicity and Safety of 2 Doses of an Investigational Herpes Zoster Subunit Vaccine Administered 2, 6 or 12 Months Apart in Adults 50 Years and Older: Results of a Phase III, Randomized, Open-Label, Multicenter Trial

Saved in:
Bibliographic Details
Published in:Open forum infectious diseases 2016-12, Vol.3 (suppl_1)
Main Authors: Poder, Airi, Geeraerts, Brecht, Lal, Himal, Oostvogels, Lidia, Abeele, Carline Vanden, Heineman, Thomas C.
Format: Article
Language:English
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:2328-8957
2328-8957
DOI:10.1093/ofid/ofw172.616